David W Denning1. 1. Global Action Fund for Fungal Infections School of Medicine, University of Manchester, Manchester, UK The National Aspergillosis Centre, University Hospital of South Manchester, Manchester, UK.
Authors: Darel Macdonald; Darren D Thomson; Anna Johns; Adriana Contreras Valenzuela; Jane M Gilsenan; Kathryn M Lord; Paul Bowyer; David W Denning; Nick D Read; Michael J Bromley Journal: Antimicrob Agents Chemother Date: 2018-12-21 Impact factor: 5.191
Authors: Felix Bongomin; Nelesh P Govender; Arunaloke Chakrabarti; Florence Robert-Gangneux; David R Boulware; Afia Zafar; Rita O Oladele; Malcolm D Richardson; Jean-Pierre Gangneux; Ana Alastruey-Izquierdo; Joel Bazira; Tom H Boyles; Jahit Sarcarlal; Mathieu Nacher; Taminori Obayashi; William Worodria; Alessandro C Pasqualotto; David B Meya; Ben Cheng; Charlotte Sriruttan; Conrad Muzoora; Andrew Kambugu; Juan Luis Rodriguez Tudela; Alexander Jordan; Tom M Chiller; David W Denning Journal: Eur J Clin Microbiol Infect Dis Date: 2019-09 Impact factor: 3.267
Authors: M R Edwards; R P Walton; D J Jackson; W Feleszko; C Skevaki; T Jartti; H Makrinoti; A Nikonova; I P Shilovskiy; J Schwarze; S L Johnston; M R Khaitov Journal: Allergy Date: 2017-08-10 Impact factor: 13.146